Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$91.6M |
| 2 |
Abbott
ABT
|
+$75M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$74.8M |
| 4 |
JPMorgan Chase
JPM
|
+$69.6M |
| 5 |
Alibaba
BABA
|
+$68.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$96.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$92.4M |
| 3 |
Johnson Controls International
JCI
|
+$76.9M |
| 4 |
Dollar General
DG
|
+$76.8M |
| 5 |
Boston Scientific
BSX
|
+$73.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.75% |
| 2 | Consumer Discretionary | 13.2% |
| 3 | Financials | 11.45% |
| 4 | Industrials | 10.99% |
| 5 | Healthcare | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
PUT
Bristol-Myers Squibb
BMY
$137B
| $11.8M | 0.1% |
+200,000
| New | +$12M |
|
302
PUT
MGM Resorts International
MGM
$11B
| $11.8M | 0.1% |
700,000
+450,000
| +180% | +$7.27M |
|
303
PVH
PVH
$3.62B
| $11.7M | 0.1% |
+242,663
| New | +$11.3M |
|
304
Lennox International
LII
$13.9B
| $11.5M | 0.1% |
49,458
+20,581
| +71% | +$4.16M |
|
305
Haemonetics
HAE
$4.95B
| $11.3M | 0.1% |
+126,424
| New | +$12.8M |
|
|
WCC
306
WESCO International
WCC
$17B
| $11.3M | 0.1% |
322,461
-119,519
| -27% | -$3.57M |
|
307
GoDaddy
GDDY
$12.3B
| $11.2M | 0.1% |
152,959
-27,184
| -15% | -$1.95M |
|
308
Stanley Black & Decker
SWK
$15.1B
| $11.1M | 0.1% |
79,869
-12,468
| -14% | -$1.5M |
|
309
PUT
United Parcel Service
UPS
$86.8B
| $11.1M | 0.1% |
+100,000
| New | +$9.98M |
|
310
Marvell Technology
MRVL
$213B
| $11.1M | 0.1% |
+315,793
| New | +$9.25M |
|
311
Angi Inc
ANGI
$200M
| $11.1M | 0.1% |
+90,965
| New | +$8.29M |
|
312
NNN REIT
NNN
$8.8B
| $11M | 0.1% |
310,627
+299,772
| +2,762% | +$9.8M |
|
313
State Street Utilities Select Sector SPDR ETF
XLU
$22.2B
| $10.9M | 0.09% |
386,074
+231,060
| +149% | +$6.66M |
|
314
Ingevity
NGVT
$2.42B
| $10.9M | 0.09% |
206,616
+197,541
| +2,177% | +$9.38M |
|
315
QuidelOrtho
QDEL
$1.01B
| $10.8M | 0.09% |
+48,384
| New | +$7.58M |
|
316
Box
BOX
$4.56B
| $10.8M | 0.09% |
519,935
+320,313
| +160% | +$5.62M |
|
317
Children's Place
PLCE
$55.4M
| $10.8M | 0.09% |
287,601
+21,779
| +8% | +$740K |
|
318
Zillow
Z
$8.07B
| $10.7M | 0.09% |
186,512
-78,337
| -30% | -$3.89M |
|
319
Ingredion
INGR
$6.74B
| $10.7M | 0.09% |
+128,745
| New | +$10.5M |
|
320
CALL
Norwegian Cruise Line
NCLH
$7.92B
| $10.7M | 0.09% |
+650,000
| New | +$9.52M |
|
321
CALL
Seagate
STX
$193B
| $10.7M | 0.09% |
+220,000
| New | +$11M |
|
322
Cognizant
CTSH
$27.9B
| $10.6M | 0.09% |
+186,957
| New | +$10M |
|
323
Pembina Pipeline
PBA
$28.3B
| $10.6M | 0.09% |
+424,319
| New | +$9.82M |
|
324
CALL
AstraZeneca
AZN
$257B
| $10.6M | 0.09% |
+100,000
| New | +$10.3M |
|
325
ICICI Bank
IBN
$107B
| $10.6M | 0.09% |
+1,137,042
| New | +$10.1M |
|
Similar funds
Dmitry Balyasny's Q2 2020 Portfolio in Review
As of Q2 2020, Dmitry Balyasny held 1,665 positions worth $11.5B, up 37% from $8.43B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Dmitry Balyasny deployed $1.48B of net new capital in Q2 2020, opening 559 new positions and adding to 260 existing holdings. Its largest new stake was Charles Schwab: 2,556,974 shares worth $86.3M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $96.4M trimmed.
- Dmitry Balyasny's largest Q2 2020 buy was Charles Schwab: 2,556,974 shares worth $86.3M.
- Dmitry Balyasny added most to Fiserv Inc in Q2 2020, an estimated $74.8M increase.
- Dmitry Balyasny's biggest Q2 2020 reduction was Lowe's Companies, cutting an estimated $96.4M.
- Dmitry Balyasny fully exited Allergan plc in Q2 2020, selling an estimated $92.4M.
- Dmitry Balyasny's ten largest holdings make up 9.4% of its $11.5B portfolio in Q2 2020.
- Dmitry Balyasny opened 559 new positions and closed 589 in Q2 2020.
- Dmitry Balyasny's portfolio value rose 37% quarter-over-quarter to $11.5B.
Based on Balyasny Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.